comparemela.com

Kelly Banas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kelly Banas, Ph D , To Present Her Latest Discovery at CRISPR Medicine’s First International Conference

Kelly Banas, Ph D , To Present Her Latest Discovery at CRISPR Medicine’s First International Conference
milfordlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from milfordlive.com Daily Mail and Mail on Sunday newspapers.

In push for women scientists, ChristianaCare leads by example

In push for women scientists, ChristianaCare leads by example
modernhealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernhealthcare.com Daily Mail and Mail on Sunday newspapers.

CRISPR-Induced Gene Products Control Response to Therapy in Lung Cancer Cells

CRISPR-directed knockout of NRF2 holds promise for improving response to chemotherapy in non-small cell lung carcinoma.

Gene editing

Gene editing Gene editing UD grads find success working at ChristianaCare’s Gene Editing Institute Natalia Rivera-Torres, Brett Sansbury and Kelly Banas are still in the early stages of their professional careers. But already, these research scientists working at ChristianaCare’s Gene Editing Institute have earned national recognition for their work with CRISPR technology, expanding the use of gene editing to improve the diagnosis and treatment of diseases like cancer while also helping to increase access to gene editing techniques for the next generation of researchers. Rivera-Torres, who graduated from the University of Delaware in 2019 with a doctorate in medical sciences from the Department of Medical and Molecular Sciences, is credited with helping researchers understand how gene repair is carried out in human cells and also how the process may vary in patient samples. She was also the first graduate student to receive a research fellowship award from the And

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.